Back
Day Range
$154.19
$161.16
52-Week Range
$91.86
$228.88
Volume
426,167
50D / 200D Avg
$186.54
/
$173.06
Prev Close
$158.00
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -54.3 | 0.4 |
| P/B | 2.5 | 2.9 |
| ROE % | -4.4 | 3.7 |
| Net Margin % | -3.6 | 3.9 |
| Rev Growth 5Y % | 3.2 | 10.0 |
| D/E | 1.0 | 0.2 |
Analyst Price Target
Hold
$202.17
+27.0%
Low: $175.00
High: $260.00
Forward P/E
14.3
Forward EPS
$11.07
EPS Growth (est.)
+0.0%
Est. Revenue
4 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$15.50
$15.36 – $15.63
|
4.6 B | 1 |
| FY2029 |
$14.07
$13.94 – $14.19
|
4.6 B | 1 |
| FY2028 |
$13.18
$13.07 – $13.30
|
4.3 B | 1 |
Key Takeaways
Revenue grew 3.20% annually over 5 years — modest growth
Earnings declined -1501.75% over the past year
Generating 518.49M in free cash flow
PEG of 0.05 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 4.05%
Capital efficient — spends only 5.46% of revenue on capex
Growth
Revenue Growth (5Y)
3.20%
Revenue (1Y)-0.85%
Earnings (1Y)-1501.75%
FCF Growth (3Y)19.13%
Quality
Return on Equity
-4.36%
ROIC6.11%
Net Margin-3.59%
Op. Margin12.65%
Safety
Debt / Equity
0.97
Current Ratio1.29
Interest Coverage4.74
Valuation
P/E Ratio
-54.29
P/B Ratio2.48
EV/EBITDA21.05
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0.85% | Revenue Growth (3Y) | -1.39% |
| Earnings Growth (1Y) | -1501.75% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 3.20% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4.02B | Net Income (TTM) | -144.34M |
| ROE | -4.36% | ROA | -2.02% |
| Gross Margin | 30.52% | Operating Margin | 12.65% |
| Net Margin | -3.59% | Free Cash Flow (TTM) | 518.49M |
| ROIC | 6.11% | FCF Growth (3Y) | 19.13% |
| Safety | |||
| Debt / Equity | 0.97 | Current Ratio | 1.29 |
| Interest Coverage | 4.74 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -54.29 | P/B Ratio | 2.48 |
| P/S Ratio | 1.95 | PEG Ratio | 0.05 |
| EV/EBITDA | 21.05 | Dividend Yield | 0.00% |
| Market Cap | 7.84B | Enterprise Value | 10.69B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.02B | 4.05B | 4.13B | 3.98B | 3.54B |
| Net Income | -144.34M | 10.30M | 474.62M | 486.23M | 390.98M |
| EPS (Diluted) | -2.91 | 0.20 | 9.22 | 9.48 | 7.60 |
| Gross Profit | 1.23B | 1.33B | 1.50B | 1.46B | 1.33B |
| Operating Income | 507.84M | 227.35M | 617.26M | 650.98M | 589.86M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 7.14B | 7.53B | 8.20B | 7.60B | 7.02B |
| Total Liabilities | 3.92B | 4.02B | 4.54B | 4.58B | 4.43B |
| Shareholders' Equity | 3.16B | 3.46B | 3.60B | 2.98B | 2.53B |
| Total Debt | 3.07B | 2.72B | 3.07B | 3.10B | 3.21B |
| Cash & Equivalents | 213.77M | 194.61M | 276.77M | 233.91M | 245.24M |
| Current Assets | 1.45B | 1.40B | 1.61B | 1.44B | 1.27B |
| Current Liabilities | 1.12B | 994.10M | 1.06B | 1.09B | 1.03B |